葡萄糖蛋白调节葡萄糖恒温:准肝脏
Yujia Ou1,2, Yuehong Guo1,2, Haoyu Wang1
1College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China. zbdfst@163.com.
Food & function
|June 25, 2024
概括
在高血糖小鼠中,Porphyra haitanensis糖蛋白 (PG) 有效调节肝脏葡萄糖代谢. 这项研究揭示了PG PG.
科学领域:
- 生物化学和分子生物学
- 药理学和毒理学 药理学和毒理学
- 海洋生物技术 海洋生物技术
背景情况:
- 高血糖症对健康构成重大风险,需要新的治疗策略.
- 自然化合物越来越多地被探索它们在治疗代谢障碍方面的潜力.
- 海洋藻*Porphyra haitanensis*及其组成部分需要对其生物活性特性进行研究.
研究的目的:
- 为了研究*Porphyra haitanensis*糖蛋白 (PG) 对肝脏葡萄糖代谢的影响.
- 在高血糖小鼠模型中阐明PG作用的潜在分子机制.
- 评估PG作为天然抗糖尿病剂的潜力.
主要方法:
- 在高血糖小鼠模型中给予不同度的PG (30-300毫克/公斤-1).
- 对肝脏基因表达的分析,重点关注关键的代谢和胰岛素相关基因.
- 对肝脏代谢物进行分析,以评估葡萄糖代谢途径的变化.
主要成果:
- PG显示了参与胰岛素信号传递 (Ins1, Ins2, Insr) 和葡萄糖利用 (Gys2, Gpi1, Gck) 的基因的度依赖上调.
- 与葡萄糖产生相关的PG下调基因 (G6pc,G6pc2,G6pc3).
- PG调节的肝脏代谢物度,包括葡萄糖,乳酸,2-氨基酸酸和葡萄糖-1-酸,表明对糖解和糖原合成的影响.
结论:
- 来自*Porphyra haitanensis*的糖蛋白通过影响胰岛素分泌,糖解/葡萄糖生成和AMPK信号通路来调节肝脏的葡萄糖代谢.
- PG促进胰岛素分泌,糖原合成和糖解,有助于改善血糖平衡.
- 这些发现支持P. haitanensis及其糖蛋白作为新型天然抗糖尿病化合物的发展.
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K
Overview of Carbohydrate Metabolism
902
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
902
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Hypoglycemia and Glucagon
256
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
256


